Mathias Due Buron

424 total citations
13 papers, 218 citations indexed

About

Mathias Due Buron is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Mathias Due Buron has authored 13 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Rheumatology and 2 papers in Neurology. Recurrent topics in Mathias Due Buron's work include Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Mathias Due Buron is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Systemic Lupus Erythematosus Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Mathias Due Buron collaborates with scholars based in Denmark, United Kingdom and Australia. Mathias Due Buron's co-authors include Melinda Magyari, Finn Sellebjerg, Per Soelberg Sørensen, Zsolt Illés, Peter Vestergaard Rasmussen, Matthias Kant, Thor Petersen, Viktoria Papp, Jeppe Romme Christensen and Henrik Boye Jensen and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Mathias Due Buron

13 papers receiving 215 citations

Peers

Countries citing papers authored by Mathias Due Buron

Since Specialization

Citations

This map shows the geographic impact of Mathias Due Buron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Due Buron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Due Buron more than expected).

Fields of papers citing papers by Mathias Due Buron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Due Buron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Due Buron. The network helps show where Mathias Due Buron may publish in the future.

Co-authorship network of co-authors of Mathias Due Buron

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Due Buron. A scholar is included among the top collaborators of Mathias Due Buron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Due Buron. Mathias Due Buron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Natalizumab treatment of multiple sclerosis — a Danish nationwide study with 13 years of follow-up 2023 ·Multiple Sclerosis and Related Disorders ·Mathias Due Buron, Jeppe Romme Christensen, Luigi Pontieri, Hanna Joensen, Matthias Kant, Peter Vestergaard Rasmussen, Finn Sellebjerg, Per Soelberg Sørensen, (unknown), Melinda Magyari	3
2	Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Mathias Due Buron, Tine Iskov Kopp, Karsten Thielen, Finn Sellebjerg, Melinda Magyari	13
3	Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks 2022 ·Frontiers in Neurology ·(unknown), (unknown), Mathias Due Buron, Melinda Magyari	6
4	Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry 2021 ·PLoS ONE ·Viktoria Papp, Mathias Due Buron, Volkert Siersma, Peter Vestergaard Rasmussen, Zsolt Illés, Matthias Kant, (unknown), J. Zs. Mezei, Homayoun Roshanisefat, Tobias Sejbæk, (unknown), (unknown), Svend Sparre Geertsen, Stephan Bramow, Finn Sellebjerg, Melinda Magyari	11
5	Late-onset MS is associated with an increased rate of reaching disability milestones 2021 ·Journal of Neurology ·(unknown), Mathias Due Buron, Melinda Magyari	18
6	Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study 2021 ·Journal of Neurology Neurosurgery & Psychiatry ·Mathias Due Buron, Tomáš Kalinčík, Finn Sellebjerg, Per Soelberg Sørensen, Melinda Magyari	7
7	Initial high-efficacy disease-modifying therapy in multiple sclerosis 2020 ·Neurology ·Mathias Due Buron, (unknown), Finn Sellebjerg, (unknown), (unknown), Jeppe Romme Christensen, (unknown), (unknown), Zsolt Illés, Henrik Boye Jensen, Matthias Kant, Viktoria Papp, Thor Petersen, (unknown), Peter Vestergaard Rasmussen, (unknown), (unknown), (unknown), Per Soelberg Sørensen, Melinda Magyari	107
8	Late-onset Multiple Sclerosis is associated with an increased rate of reaching Disability Milestones (760) 2020 ·Neurology ·(unknown), Mathias Due Buron, Melinda Magyari	1
9	Comparative effectiveness of teriflunomide and dimethyl fumarate 2019 ·Neurology ·Mathias Due Buron, (unknown), Finn Sellebjerg, Jette Lautrup Frederiksen, (unknown), Zsolt Illés, Matthias Kant, J. Zs. Mezei, Thor Petersen, Peter Vestergaard Rasmussen, Homayoun Roshanisefat, (unknown), Tobias Sejbæk, (unknown), (unknown), Per Soelberg Sørensen, Melinda Magyari	29
10	Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Mathias Due Buron, Zsolt Illés, Viktoria Papp, (unknown), (unknown), (unknown), Nasrin Asgari, (unknown), Henrik Boye Jensen, Per Soelberg Sørensen, Melinda Magyari	12
11	Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β 2019 ·Multiple Sclerosis and Related Disorders ·Mathias Due Buron, Melinda Magyari, (unknown), Per Soelberg Sørensen, Finn Sellebjerg	2
12	Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study 2018 ·BMC Cardiovascular Disorders ·Christine Benn Christiansen, Christian Torp‐Pedersen, Jonas Bjerring Olesen, Gunnar Gislason, Morten Lamberts, Nicholas Carlson, Mathias Due Buron, (unknown), Gregory Y.H. Lip	2
13	Oral presentations 2018 ·Multiple Sclerosis Journal ·Mathias Due Buron, Melinda Magyari, (unknown), (unknown), Zsolt Illés, (unknown), Homayoun Roshanisefat, (unknown), Thor Petersen, (unknown), Finn Sellebjerg, Per Soelberg Sørensen	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact